Table 1. Mean concentration of fasting glucose, insulin and HOMA-IR scores in antipsychotic drug treated rats.
Antipsychotic Drug | Measure | Treatment Dose (mg/kg) | |||
0 | 0.2 | 0.8 | 2 | ||
Lurasidone | G0 | 5.6±0.1 | 5.4±0.3 | 5.3±0.2 | 5.2±0.2 |
I0 | 10.0±0.7 | 10.4±0.8 | 9.5±0.7 | 10.4±0.9 | |
HOMA-IR | 2.5±0.2 | 2.5±0.2 | 2.2±0.8 | 2.5±0.3 | |
10 | |||||
Olanzapine | G0 | 5.5±0.2 | |||
I0 | 22.9±5.4* | ||||
HOMA-IR | 5.8±1.5* |
I0 = fasting insulin levels (µU/ml); G0 = fasting glucose levels (mmol/L); HOMA-IR = homeostasis model assessment of insulin resistance (µU·mmol)/(ml·L).
Rats were treated with three separate doses of lurasidone (0.2, 0.8 or 2.0 mg/kg), olanzapine (10 mg/kg) or vehicle. Values represented as means ± SEM at t = 30 min during the IGTT.
*indicates different from vehicle-treated animals, p<0.001.